Cargando…
MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer
OBJECTIVE: EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2) and has been documented as an oncogene in breast cancer. The microRNA (miR)-101-3p can suppress breast cancer progression by targeting with EZH2. Syn-cal14.1a, a synthetic peptide derived from Californiconus califor...
Autores principales: | Jiang, Huabo, Li, Li, Zhang, Jingjing, Wan, Zhong, Wang, Yuanyuan, Hou, Jingjing, Yu, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532305/ https://www.ncbi.nlm.nih.gov/pubmed/33061442 http://dx.doi.org/10.2147/OTT.S264600 |
Ejemplares similares
-
Overexpression of miR-101 suppresses collagen synthesis by targeting EZH2 in hypertrophic scar fibroblasts
por: Li, Jie, et al.
Publicado: (2021) -
lncRNA MALAT1 promotes cell proliferation and invasion by regulating the miR-101/EZH2 axis in oral squamous cell carcinoma
por: Xiao, Lei, et al.
Publicado: (2020) -
Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth
por: Qu, Fu-Lian, et al.
Publicado: (2015) -
In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii
por: De León-Nava, Marco A., et al.
Publicado: (2016) -
SynBa: improved estimation of drug combination synergies with uncertainty quantification
por: Zhang, Haoting, et al.
Publicado: (2023)